About Biosimilars Biosimilars or follow-on biologics are generic versions of the biopharmaceutical products. These are developed following the patent expiry of an original molecule. Biosimilars have the same biological properties as original drugs and target the same diseases. They have many similarities but are not identical to the reference biopharmaceutical product. The analysts forecast spending on the global monoclonal antibody (mAb) biosimilars market to grow at a CAGR of 4-7% during the period 2015-2020. Covered in this report This report cove...more >>
from Infiniti Research Limited Market Research Reports http://ift.tt/2dtfdde
